Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist(TM) Automated Insulin Delivery (AID) System

Stock Information for Senseonics Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Senseonics Holdings Inc.

Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
Senseonics Announces Transfer to Nasdaq Stock Exchange
Senseonics Holdings, Inc. Reports Third Quarter Financial Results
Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.